Search

Your search keyword '"Grange, Claire"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Grange, Claire" Remove constraint Author: "Grange, Claire"
133 results on '"Grange, Claire"'

Search Results

2. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

4. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

5. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

6. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

7. Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial

8. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

13. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

14. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

15. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

16. Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study.

17. Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

19. Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

20. Traitement curatif de la maladie thromboembolique veineuse et prise en charge des thromboses veineuses sur cathéter chez les patients atteints de cancer: Méthode SOR

21. Evaluation of interleukin 13 polymorphisms in systemic sclerosis

22. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

24. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis

25. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis.

28. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

29. Scaling up quality improvement intervention for perinatal care in Nepal (NePeriQIP); study protocol of a cluster randomised trial

32. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis:the European Scleroderma Observational Study

33. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study

34. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

35. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

36. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

37. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study

38. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

39. Treatment outcome in early diffuse cutaneous systemic sclerosis:the European Scleroderma Observational Study (ESOS)

40. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

41. [Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients]

42. [2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients]

43. [2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]

44. [Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer]

45. IL13RA2 gene polymorphisms are associated with systemic sclerosis

46. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

47. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

48. Update of Laser Mégajoule large optics wavefront performance requirements

49. LIL laser performance status

50. 2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Catalog

Books, media, physical & digital resources